A large-scale, multi-year, public-private partnership that uses genetics and genomics data for systematic drug target identification and prioritization.
Finding the best targets to safely & effectively treat disease Helping others find good targets Getting targets adopted into drug discovery pipelines
Publicly available information relevant to diseases